Auro Laboratories Ltd.
BSE: 530233 | Sector: Health care |
NSE: N.A. | ISIN Code: INE292C01011 |
BSE 00:00 | 17 May | 96.95 |
2.60 (2.76%) |
OPEN
95.95 |
HIGH
98.60 |
LOW
92.35 |
NSE 05:30 | 01 Jan | Auro Laboratories Ltd Not listed in NSE |
OPEN | 95.95 |
PREVIOUS CLOSE | 94.35 |
VOLUME | 2665 |
52-Week high | 195.00 |
52-Week low | 87.00 |
P/E | 15.46 |
Mkt Cap.(Rs cr) | 60 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
About Auro Laboratories Ltd.
Auro Laboratories is a manufacturer of Active Pharmaceutical Ingredients (API's) Intermediates and Generic Formulations. Auro Laboratories was founded and incorporated in 1992 at Mumbai with a manufacturing facility located at Tarapur 120 Km from Mumbai. Since inception the company has focused on providing quality pharmaceuticals while maintaining high manufacturing standards.The company's primary...> More
Auro Laboratories Ltd - Key Fundamentals
Parameter | Values | ||
Market Cap | (![]() |
60 | |
EPS - TTM | (![]() |
[*S] | 6.27 |
P/E Ratio | (X) | [*S] | 15.46 |
Face Value | (![]() |
10 | |
Latest Dividend | (%) | - | |
Latest Dividend Date | - | ||
Dividend Yield | (%) | 0.00 | |
Book Value / Share | (![]() |
[*S] | 48.64 |
P/B Ratio | (![]() |
[*S] | 1.99 |
Announcement
-
Format of Initial Disclosure to be made by an entity identified as a Large Corporate
-
Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Require
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
-
Statement Of Investor Complaints For The Quarter Ended March 2022
-
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
-
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
Auro Laboratories Ltd - Financial Results
Particulars (![]() |
Dec 2021 | Dec 2020 | % Chg |
Net Sales | 12.14 | 13.11 | -7.4 |
Other Income | 0.02 | 0.25 | -92 |
Total Income | 12.16 | 13.36 | -8.98 |
Total Expenses | 10.92 | 10.25 | 6.54 |
Operating Profit | 1.24 | 3.11 | -60.13 |
Net Profit | 0.61 | 2.03 | -69.95 |
Equity Capital | 6.23 | 6.23 | - |
Auro Laboratories Ltd - Peer Group
Company | Price(![]() |
Chg (%) | Mkt Cap (![]() |
BDH Industries | 125.10 | 1.79 | 72.06 |
Medi Caps | 53.35 | 1.04 | 66.53 |
Sandu Pharma. | 72.55 | -0.62 | 63.92 |
Auro Labs. | 96.95 | 2.76 | 60.40 |
Vivo Bio Tech | 39.70 | 0.00 | 59.07 |
Source Natural | 90.40 | -0.22 | 58.22 |
Mercury Labs | 475.50 | -1.76 | 57.06 |
Auro Laboratories Ltd - SHAREHOLDING PATTERN
|
|
Auro Laboratories Ltd - RETURNS
Period | BSE | NSE | Sensex | NIFTY |
1 Week | 3.14% | NA | -0.09% | 0.12% |
1 Month | -12.22% | NA | -6.89% | -6.96% |
3 Month | -2.71% | NA | -6.17% | -6.04% |
6 Month | -9.35% | NA | -9.48% | -9.16% |
1 Year | -5.51% | NA | 9.56% | 8.95% |
3 Year | 55.49% | NA | 43.20% | 42.54% |
Auro Laboratories Ltd - STOCK STRENGTH
Today's Low/High | 92.35 | 98.60 | |
Week Low/High | 87.20 | 98.60 | |
Month Low/High | 87.20 | 114.00 | |
YEAR Low/High | 87.00 | 195.00 | |
All TIME Low/High | 0.70 | 195.00 |
Quick Links for Auro Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices